Evaluation of the effectiveness of artemether-lumefantrine and artesunate-pyronaridine each combined with single low-dose primaquine in adults with Plasmodium falciparum infection in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-group trial.

Bezabih MK, Misganaw T, Ejigu LA, Rosillo S, Teka H, Alemayehu DH, Adnew B, Hailegiorgis B, Girma S, Tadesse M, Kassa FA, Gebremichael M, Tefera DA, Chali W, Behaksera SW, Alemayehu L, Deressa JD, Abdo M, Habtamu G, Gizat A, Yalew WG, Jember TH, Bitew M, Mumba P, Plucinski MM, Souza S, Patel DS, Talundzic E, Taffese HS, Geleta KE, Mehari D, Bayissa GA, Bousema T, Tongren JE, Hwang J, Tadesse FG

Open source

DOI
10.1016/j.lanmic.2025.101344
Published
2026 Aug
Container
The Lancet. Microbe
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lanmic.2025.101344,
  title = {Evaluation of the effectiveness of artemether-lumefantrine and artesunate-pyronaridine each combined with single low-dose primaquine in adults with Plasmodium falciparum infection in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-group trial.},
  author = {Bezabih MK and Misganaw T and Ejigu LA and Rosillo S and Teka H and Alemayehu DH and Adnew B and Hailegiorgis B and Girma S and Tadesse M and Kassa FA and Gebremichael M and Tefera DA and Chali W and Behaksera SW and Alemayehu L and Deressa JD and Abdo M and Habtamu G and Gizat A and Yalew WG and Jember TH and Bitew M and Mumba P and Plucinski MM and Souza S and Patel DS and Talundzic E and Taffese HS and Geleta KE and Mehari D and Bayissa GA and Bousema T and Tongren JE and Hwang J and Tadesse FG},
  year = {2026},
  journal = {The Lancet. Microbe},
  doi = {10.1016/j.lanmic.2025.101344},
  url = {https://doi.org/10.1016/j.lanmic.2025.101344}
}

RIS

TY  - JOUR
TI  - Evaluation of the effectiveness of artemether-lumefantrine and artesunate-pyronaridine each combined with single low-dose primaquine in adults with Plasmodium falciparum infection in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-group trial.
AU  - Bezabih MK
AU  - Misganaw T
AU  - Ejigu LA
AU  - Rosillo S
AU  - Teka H
AU  - Alemayehu DH
AU  - Adnew B
AU  - Hailegiorgis B
AU  - Girma S
AU  - Tadesse M
AU  - Kassa FA
AU  - Gebremichael M
AU  - Tefera DA
AU  - Chali W
AU  - Behaksera SW
AU  - Alemayehu L
AU  - Deressa JD
AU  - Abdo M
AU  - Habtamu G
AU  - Gizat A
AU  - Yalew WG
AU  - Jember TH
AU  - Bitew M
AU  - Mumba P
AU  - Plucinski MM
AU  - Souza S
AU  - Patel DS
AU  - Talundzic E
AU  - Taffese HS
AU  - Geleta KE
AU  - Mehari D
AU  - Bayissa GA
AU  - Bousema T
AU  - Tongren JE
AU  - Hwang J
AU  - Tadesse FG
PY  - 2026
JO  - The Lancet. Microbe
DO  - 10.1016/j.lanmic.2025.101344
UR  - https://doi.org/10.1016/j.lanmic.2025.101344
ER  -

APA

MK, B., T, M., LA, E., S, R., H, T., DH, A., B, A., B, H., S, G., M, T., FA, K., M, G., DA, T., W, C., SW, B., L, A., JD, D., M, A., G, H., A, G., WG, Y., TH, J., M, B., P, M., MM, P., S, S., DS, P., E, T., HS, T., KE, G., D, M., GA, B., T, B., JE, T., J, H., & FG, T. (2026). Evaluation of the effectiveness of artemether-lumefantrine and artesunate-pyronaridine each combined with single low-dose primaquine in adults with Plasmodium falciparum infection in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-group trial.. The Lancet. Microbe. https://doi.org/10.1016/j.lanmic.2025.101344

Source records